BioPharm International
April 01, 2012
Burrill on Biotech
25
4
Better news about the global economy buoys life-sciences funding.
April 01, 2012
Features
25
4
Industry experts discuss the benefits and challenges of self-administration of injectable therapies.
April 01, 2012
Features
25
4
A technical rountable featuring Sartorius Stedim Biotech, Pall Life Sciences, 3M Purification, Asahi Kasei Bioprocess, and Bio-Rad Laboratories.
April 01, 2012
Compliance Notes
25
4
FDA has created a dedicated cadre of foreign drug investigators and established permanent offices worldwide.
April 01, 2012
Final Word
25
4
Rather than seeking a single indication for one large group, the orphan-drug approach segments the market for a drug more minutely.
April 01, 2012
Regulatory Beat
25
4
Soaring opioid use creates challenges for new drug development and supply-chain control.
April 01, 2012
Manufacturing Best Practices
25
4
A closer look at elastomer changeout times provides one example of using industry knowledge to improve operations and cost.
April 01, 2012
Features
25
4
The authors discuss the technology and guidance required to achieve good KM in a biopharmaceutical company.
April 01, 2012
Perspectives on Outsourcing
25
4
Recovery audits and other best practices in procurement can improve the bottom line.
April 01, 2012
Features
25
4
The authors describe a new assembly for bulk and final drug product filling operations.
April 01, 2012
Boot Camp Business Guide
25
4
BioPharm talks with Tarja Mottram, CEO of Action for Results, about key business considerations when starting out.
April 01, 2012
Features
25
4
This month, we rewind to an article titled "Good Manufacturing Practices Training."
April 01, 2012
Guest Editorial
25
4
Collaboration can begin with a conversation.
April 01, 2012
Guest Editorial
25
4
The confluence of science, technology, and regulation will provide our industry with the guidance to move forward.